mHealth Intelligence November 2, 2023
Anuja Vaidya

New research shows that using hormone data gathered by wearable devices can help clinicians determine cancer growth and provide personalized care.

Researchers at the University of Virginia Health (UVA Health) have found that wearable devices can be used to glean insights into patients’ cortisol levels, enabling clinicians to identify and provide personalized care to at-risk cancer patients.

The research is still in its early stages, but UVA Health researchers have discovered that pancreatic cancer patients with high cortisol levels resulting from disrupted sleep will experience faster tumor growth.

Scientific literature shows that there is a robust link between cancer patients’ health behaviors and their tumor progression. Hormones associated with these behaviors, such as cortisol and melatonin, have also been found...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Patient / Consumer, Provider, Technology, Wearables
Oura Ring Is ‘Like An Apple Product’ And Could Take Key Health Metric Mainstream
Wearable ultrasound sensor revolutionizes continuous blood pressure monitoring
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review

Share This Article